Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-31

Clinical Trial Update: Feasibility Study of Renal Denervation for the Treatment of Resistant Hypertension [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 feasibility trial is evaluating renal denervation for resistant (uncontrolled) hypertension; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sound Interventions, Inc. | Conditions: Uncontrolled Hypertension | EARLY_Phase 1 | Status: UNKNOWN